Literature DB >> 16083865

Bilateral enhancement of excitation via up-regulation of vesicular glutamate transporter subtype 1, not subtype 2, immunoreactivity in the unilateral hypoxic epilepsy model.

Duk-Soo Kim1, Sung-Eun Kwak, Ji-Eun Kim, Moo Ho Won, Hui-Chul Choi, Hong-Ki Song, Oh-Shin Kwon, Yeong-In Kim, Soo-Young Choi, Tae-Cheon Kang.   

Abstract

In the present study, the change of vesicular glutamate transporter (VGLUT) immunoreactivity on long-term impaired excitability in the hippocampus after recovery from unilateral hypoxic-ischemic insult was investigated in order to extend our understanding of the mechanism of epileptogenesis using unilateral hypoxic epilepsy models. Both the lesioned (submitted to ischemia) and the unlesioned hippocampi exhibited the frequent occurrence of interictal spikes and occasionally the sustained ictal discharges. However, paired-pulse inhibition was significantly reduced in the unlesioned dentate gyrus, not in the lesioned dentate gyrus. VGLUT1 immunoreactivity was significantly elevated in both hippocampi following hypoxic ischemia, although VGLUT2 immunodensity was unaltered. These findings suggest that the enhancement of VGLUT1 immunoreactivity in both hippocampi after unilateral hypoxic ischemia may contribute to the hyperexcitability, which may play an important role in the epileptogenesis (presumably accompanied by altered inhibitory transmission) after neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083865     DOI: 10.1016/j.brainres.2005.06.081

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity.

Authors:  Pushpa Verma; George J Augustine; Mohamed-Raafet Ammar; Ayumu Tashiro; Stephen M Cohen
Journal:  Nat Neurosci       Date:  2015-02-02       Impact factor: 24.884

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Histone Deacetylase 4 Downregulation Elicits Post-Traumatic Psychiatric Disorders through Impairment of Neurogenesis.

Authors:  Pampa Saha; Rajaneesh Gupta; Tanusree Sen; Nilkantha Sen
Journal:  J Neurotrauma       Date:  2019-08-01       Impact factor: 5.269

4.  Alterations in serotonin receptors and transporter immunoreactivities in the hippocampus in the rat unilateral hypoxic-induced epilepsy model.

Authors:  Sung-Jin An; Duk-Soo Kim
Journal:  Cell Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.046

5.  Vesicular Glutamate Transporter Inhibitors: Structurally Modified Brilliant Yellow Analogs.

Authors:  Jason Kehrl; J Christian Althaus; Hollis D Showalter; DiAndra M Rudzinski; Michael A Sutton; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2017-03-02       Impact factor: 3.996

6.  Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration.

Authors:  Richard W Daniels; Bradley R Miller; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2010-10-14       Impact factor: 5.996

7.  Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.

Authors:  Thomas Steinkellner; Vivien Zell; Zachary J Farino; Mark S Sonders; Michael Villeneuve; Robin J Freyberg; Serge Przedborski; Wei Lu; Zachary Freyberg; Thomas S Hnasko
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

Review 8.  Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Authors:  Joeri Van Liefferinge; Ann Massie; Jeanelle Portelli; Giuseppe Di Giovanni; Ilse Smolders
Journal:  Front Cell Neurosci       Date:  2013-08-30       Impact factor: 5.505

9.  A systems level, functional genomics analysis of chronic epilepsy.

Authors:  Kellen D Winden; Stanislav L Karsten; Anatol Bragin; Lili C Kudo; Lauren Gehman; Josephine Ruidera; Daniel H Geschwind; Jerome Engel
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

10.  Knock-Out of Tenascin-C Ameliorates Ischemia-Induced Rod-Photoreceptor Degeneration and Retinal Dysfunction.

Authors:  Susanne Wiemann; Aisha Yousf; Stephanie C Joachim; Carolin Peters; Ana M Mueller-Buehl; Natalie Wagner; Jacqueline Reinhard
Journal:  Front Neurosci       Date:  2021-05-20       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.